🔷 Condition — Disseminated Intravascular Coagulation (DIC)
❤️The client with sepsis who develops petechiae, oozing from an IV site, and a large frank hematemesis fits the classic picture of consumptive coagulopathy seen in DIC.
❤️Lab findings of thrombocytopenia (platelets 100,000/mm³) with prolonged PT (20 s) and prolonged aPTT (47 s) indicate clotting factor consumption and dysregulated coagulation, which are hallmark features of DIC.
❤️The simultaneous risks of microvascular thrombosis and diffuse bleeding reflect widespread thrombin generation with secondary fibrinolysis, commonly triggered by gram-negative sepsis.
❤️Clinical deterioration—restlessness/confusion, cool clammy skin, falling blood pressure (105/64), and rising heart rate (114/min)—supports evolving shock in the setting of DIC, demanding rapid recognition and intervention.
🔷 Action — Administer heparin as prescribed
❤️In DIC, carefully provider-directed heparin can be used to interrupt ongoing thrombin generation and reduce microthrombi that drive organ ischemia, particularly when thrombosis predominates.
❤️By attenuating coagulation cascade activation, heparin may limit further consumption of platelets and factors, helping stabilize the coagulation milieu while definitive management of sepsis continues.
❤️This intervention must be individualized, balancing bleeding risk against thrombotic burden, with close monitoring and coordination with the treating team.
❤️Heparin use in DIC is adjunctive to treating the underlying cause (source control, antibiotics, fluids/vasopressors) and may be paired with blood component support per orders to correct critical deficiencies.
🔷 Action — Reposition in bed carefully
❤️Clients in DIC have fragile hemostasis; even minor shear or pressure can precipitate new cutaneous or mucosal bleeding.
❤️Gentle handling, avoiding skin trauma, and using protective padding reduce the risk of ecchymoses, hematomas, and oozing from lines or puncture sites.
❤️Careful repositioning also helps prevent pressure injuries, which would otherwise become bleeding foci in a coagulopathic patient.
❤️Combine this with limited venipunctures, avoidance of IM injections, and meticulous line care to minimize additional iatrogenic bleeding risks.
🔷 Monitor — Fibrinogen level
❤️Fibrinogen is typically low in DIC due to consumption; trending it gives a direct window into the severity of factor depletion.
❤️Falling fibrinogen suggests ongoing coagulation activation, whereas stabilization or rise indicates a therapeutic response to treating the underlying trigger and supportive therapy.
❤️Because fibrinogen is essential for clot formation, critically low levels correlate with uncontrolled bleeding risk and may prompt cryoprecipitate per provider orders.
❤️Serial measurement, alongside PT/aPTT and platelet counts, forms a core panel to track progression or resolution of DIC.
🔷 Monitor — Bleeding from other sites
❤️Continuous assessment for new or worsening bleeding (gums, urine, stool, puncture sites, mucosa, catheter/line sites) provides immediate, bedside evidence of hemostatic failure.
❤️Documenting amount, character, and location helps guide urgency of blood product support and effectiveness of interventions.
❤️Expanding bleeding often parallels worsening consumption and can herald hemodynamic instability, prompting rapid escalation.
❤️Coupled with vitals and mental status, this parameter helps evaluate response to therapy and the need for additional corrective measures.